van Rosendael, Sophie E.
Kuneman, Jurrien H.
van den Hoogen, Inge J.
Kitslaar, Pieter H.
van Rosendael, Alexander R.
van der Bijl, Pieter
Reiber, Johan H. C.
Ajmone Marsan, Nina
Jukema, J. Wouter
Knuuti, Juhani
Bax, Jeroen J.
Article History
Received: 13 June 2022
Accepted: 9 August 2022
First Online: 24 August 2022
Declarations
:
: The authors declare no competing interests.
: The department of Cardiology, Leiden University Medical Centre, Leiden, The Netherlands has received unrestricted research grants from Bayer, Abbott Vascular, Medtronic, Biotronik, Boston Scientific, GE Healthcare and Edwards Lifesciences. Dr. Bax received speaker fees from Abbott Vascular. Dr. Reiber is the is the CSO of Medis Medical Imaging Systems. P.H. Kitslaar is employee of Medis Medical Imaging Systems. Dr. Ajmone received speaker fees from Abbott Vascular and GE Healthcare. Dr. Knuuti received consultancy fees from GE Healthcare and AstraZeneca and speaker fees from GE Healthcare, Bayer, Lundbeck, Boehringer-Ingelheim, Pfizer and Merck, outside of the submitted work. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.